Del. Justices Uphold Fresenius' $4.3B Akorn Merger Drop
Delaware's Supreme Court on Friday upheld a milestone Chancery Court finding that Fresenius Kabi AG had a right to terminate a $4.3 billion deal for generic-drug developer Akorn Inc., ruling less...To view the full article, register now.
Already a subscriber? Click here to view full article